loading
Precedente Chiudi:
$12.02
Aprire:
$11.78
Volume 24 ore:
5,008
Relative Volume:
0.26
Capitalizzazione di mercato:
$8.13M
Reddito:
-
Utile/perdita netta:
$-24.05M
Rapporto P/E:
-5.8139
EPS:
-2.15
Flusso di cassa netto:
$-17.78M
1 W Prestazione:
+15.90%
1M Prestazione:
+34.41%
6M Prestazione:
-54.56%
1 anno Prestazione:
-87.51%
Intervallo 1D:
Value
$11.78
$12.50
Intervallo di 1 settimana:
Value
$10.21
$12.85
Portata 52W:
Value
$8.67
$196.70

Envveno Medical Corporation Stock (NVNO) Company Profile

Name
Nome
Envveno Medical Corporation
Name
Telefono
949-261-2900
Name
Indirizzo
70 DOPPLER, IRVINE
Name
Dipendente
37
Name
Cinguettio
Name
Prossima data di guadagno
2026-03-12
Name
Ultimi documenti SEC
Name
NVNO's Discussions on Twitter

Compare NVNO vs ABT, SYK, MDT, BSX, EW

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
NVNO
Envveno Medical Corporation
12.40 7.88M 0 -24.05M -17.78M -2.15
Medical Devices icon
ABT
Abbott Laboratories
110.09 192.10B 44.33B 6.50B 7.40B 3.717
Medical Devices icon
SYK
Stryker Corp
342.26 137.25B 25.12B 3.25B 4.28B 8.3984
Medical Devices icon
MDT
Medtronic Plc
88.89 115.41B 35.48B 4.64B 5.41B 3.582
Medical Devices icon
BSX
Boston Scientific Corp
68.85 103.81B 20.08B 2.89B 3.66B 1.9391
Medical Devices icon
EW
Edwards Lifesciences Corp
84.50 49.82B 6.07B 1.06B 1.34B 1.8063

Envveno Medical Corporation Borsa (NVNO) Ultime notizie

pulisher
Mar 10, 2026

enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Independent Mail

Mar 10, 2026
pulisher
Mar 03, 2026

NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - The Manila Times

Mar 03, 2026
pulisher
Mar 02, 2026

Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO) - Defense World

Mar 02, 2026
pulisher
Mar 01, 2026

NVNO SEC FilingsEnvveno Medical Corporation 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 01, 2026
pulisher
Feb 24, 2026

NVNO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026
pulisher
Feb 24, 2026

Can enVVeno Medical Corporation maintain sales growthQuarterly Profit Summary & Daily Growth Stock Tips - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 20, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Feb 20, 2026
pulisher
Feb 20, 2026

enVVeno Medical (NVNO) investor urges halt to trials, strategic review - Stock Titan

Feb 20, 2026
pulisher
Feb 18, 2026

enVVeno Medical Announces Reverse Stock Split - Press & Sun-Bulletin

Feb 18, 2026
pulisher
Feb 17, 2026

Perceptive funds hold 2.05M enVVeno (NVNO) shares and warrants - Stock Titan

Feb 17, 2026
pulisher
Feb 15, 2026

NVNO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 15, 2026
pulisher
Feb 11, 2026

Strategic Investor Acquires Significant Stake in enVVeno Medical - AD HOC NEWS

Feb 11, 2026
pulisher
Feb 10, 2026

Investor Braeden Lichti discloses 5.05% enVVeno (NVNO) ownership stake - Stock Titan

Feb 10, 2026
pulisher
Feb 08, 2026

Aug Analyst Calls: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 07, 2026

Head to Head Analysis: LENSAR (NASDAQ:LNSR) versus enVVeno Medical (NASDAQ:NVNO) - Defense World

Feb 07, 2026
pulisher
Feb 06, 2026

enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - The Northwest Florida Daily News

Feb 06, 2026
pulisher
Feb 06, 2026

enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - DelmarvaNow.com

Feb 06, 2026
pulisher
Feb 05, 2026

enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans - The Globe and Mail

Feb 05, 2026
pulisher
Feb 05, 2026

EnVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - News Channel Nebraska Southeast

Feb 05, 2026
pulisher
Feb 04, 2026

enVVeno Medical regains Nasdaq compliance, reports $28 million cash By Investing.com - Investing.com Nigeria

Feb 04, 2026
pulisher
Feb 04, 2026

enVVeno Medical regains compliance with Nasdaq minimum bid price rule - TipRanks

Feb 04, 2026
pulisher
Feb 04, 2026

enVVeno Medical Regains Nasdaq Compliance - Orange County Business Journal

Feb 04, 2026
pulisher
Feb 04, 2026

enVVeno Medical regains Nasdaq compliance, reports $28 million cash - Investing.com

Feb 04, 2026
pulisher
Feb 04, 2026

Bank Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Performance Recap & Smart Investment Allocation Tips - baoquankhu1.vn

Feb 04, 2026
pulisher
Feb 03, 2026

enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Green Bay Press-Gazette

Feb 03, 2026
pulisher
Feb 02, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Feb 02, 2026
pulisher
Feb 01, 2026

Breakout Zone: Why is Pliant Therapeutics Inc stock going upJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - baoquankhu1.vn

Feb 01, 2026
pulisher
Feb 01, 2026

Volume Report: Will enVVeno Medical Corporation benefit from seasonalityShort Setup & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Feb 01, 2026

Envveno Medical Corporation Azioni (NVNO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices ZBH
$93.17
price up icon 1.61%
medical_devices STE
$218.90
price down icon 1.39%
$67.68
price down icon 0.13%
medical_devices PHG
$28.70
price down icon 0.86%
$72.81
price up icon 0.07%
medical_devices EW
$84.53
price down icon 1.13%
Capitalizzazione:     |  Volume (24 ore):